Liwei Wang Selected Research

Chloride Channels (Chloride Channel)

3/2021	Interleukin 1 beta-induced chloride currents are important in osteoarthritis onset: an in vitro study.
12/2019	Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel.
1/2019	Starvation-induced autophagy is up-regulated via ROS-mediated ClC-3 chloride channel activation in the nasopharyngeal carcinoma cell line CNE-2Z.
11/2018	Opening of the CLC-3 chloride channel induced by dihydroartemisinin contributed to early apoptotic events in human poorly differentiated nasopharyngeal carcinoma cells.
10/2018	The apoptotic effect of Zoledronic acid on the nasopharyngeal carcinoma cells via ROS mediated chloride channel activation.
2/2018	Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
6/2017	Emodin suppresses the nasopharyngeal carcinoma cells by targeting the chloride channels.
3/2016	The AQP-3 water channel is a pivotal modulator of glycerol-induced chloride channel activation in nasopharyngeal carcinoma cells.
1/2016	ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells.
8/2015	Ethanol Promotes Cell Migration via Activation of Chloride Channels in Nasopharyngeal Carcinoma Cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liwei Wang Research Topics

Disease

85	Neoplasms (Cancer) 09/2022 - 08/2002
32	Stomach Neoplasms (Stomach Cancer) 12/2021 - 08/2002
29	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 01/2003
26	Nasopharyngeal Carcinoma 12/2019 - 10/2002
22	Neoplasm Metastasis (Metastasis) 05/2021 - 01/2003
15	Adenocarcinoma 01/2022 - 03/2004
9	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 01/2003
7	Carcinogenesis 11/2021 - 12/2010
6	Inflammation (Inflammations) 06/2021 - 01/2012
5	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2016
5	Lymphatic Metastasis 01/2019 - 01/2004
4	Pain (Aches) 01/2022 - 01/2017
4	Hepatocellular Carcinoma (Hepatoma) 09/2018 - 05/2013
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 04/2014
3	Wounds and Injuries (Trauma) 01/2022 - 05/2016
3	Hemorrhage 06/2021 - 01/2015
3	Lung Neoplasms (Lung Cancer) 12/2019 - 12/2013
3	Postoperative Pain 01/2018 - 01/2017
3	Carcinoma (Carcinomatosis) 11/2013 - 06/2010
2	Thrombosis (Thrombus) 04/2022 - 01/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 03/2021 - 03/2020
2	Cognitive Dysfunction 01/2021 - 01/2017
2	Alcoholism (Alcohol Abuse) 01/2021 - 11/2016
2	Hypoxia (Hypoxemia) 11/2020 - 03/2016
2	Hypertension (High Blood Pressure) 08/2020 - 06/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2020 - 11/2017
2	Neuroinflammatory Diseases 01/2020 - 01/2017
2	Rheumatoid Arthritis 12/2019 - 01/2018
2	Starvation 01/2019 - 06/2017
2	Disease Progression 01/2019 - 02/2016
2	Exanthema (Rash) 01/2019 - 06/2015
2	Postoperative Cognitive Complications 01/2019 - 01/2018
2	Diarrhea 10/2017 - 09/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 01/2010

Drug/Important Bio-Agent (IBA)

24	Chloride Channels (Chloride Channel)IBA 03/2021 - 01/2007
23	Proteins (Proteins, Gene)FDA Link 04/2022 - 07/2003
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2012
15	ChloridesIBA 03/2021 - 10/2002
14	Pharmaceutical PreparationsIBA 10/2022 - 01/2010
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 01/2003
8	Sp1 Transcription FactorIBA 07/2008 - 12/2003
7	Messenger RNA (mRNA)IBA 03/2021 - 01/2004
6	Biological ProductsIBA 01/2021 - 06/2004
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2004
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2021 - 02/2016
5	Caspase 3 (Caspase-3)IBA 03/2021 - 06/2005
5	Long Noncoding RNAIBA 11/2020 - 12/2014
5	mithramycin AIBA 08/2011 - 05/2007
4	CytokinesIBA 01/2022 - 08/2005
4	Sevoflurane (Ultane)FDA LinkGeneric 01/2022 - 12/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2013
4	AntigensIBA 11/2021 - 07/2013
4	Irinotecan (Camptosar)FDA LinkGeneric 08/2021 - 09/2013
4	Gemcitabine FDA Link 08/2021 - 08/2011
4	apatinibIBA 01/2018 - 09/2013
4	Protein Isoforms (Isoforms)IBA 04/2016 - 12/2010
4	Cyclin D1IBA 01/2016 - 06/2005
4	Cisplatin (Platino)FDA LinkGeneric 02/2015 - 10/2009
4	Bevacizumab (Avastin)FDA Link 01/2015 - 04/2007
3	LigandsIBA 01/2022 - 01/2017
3	SolutionsIBA 01/2022 - 10/2002
3	Fluorouracil (Carac)FDA LinkGeneric 08/2021 - 10/2018
3	folfirinoxIBA 08/2021 - 05/2021
3	Leucovorin (Folinic Acid)FDA Link 08/2021 - 10/2018
3	PlatinumIBA 07/2021 - 01/2017
3	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2015
3	VimentinIBA 01/2021 - 01/2020
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2020 - 01/2015
3	Trastuzumab (Herceptin)FDA Link 01/2020 - 02/2016
3	Tumor Biomarkers (Tumor Markers)IBA 02/2019 - 02/2012
3	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 03/2012
3	Small Interfering RNA (siRNA)IBA 09/2018 - 12/2007
3	Celecoxib (Celebrex)FDA Link 01/2018 - 03/2004
3	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2015 - 02/2012
3	ErbB Receptors (EGF Receptor)IBA 01/2013 - 05/2007
2	gallium 68 PSMA-11IBA 01/2022 - 09/2020
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2018
2	130-nm albumin-bound paclitaxelIBA 08/2021 - 12/2017
2	CarcinogensIBA 01/2021 - 08/2007
2	regorafenibIBA 08/2020 - 06/2015
2	Alanine Transaminase (SGPT)IBA 08/2020 - 06/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2020 - 06/2015
2	Tyrosine Kinase InhibitorsIBA 05/2020 - 05/2016
2	Cadherins (E-Cadherin)IBA 01/2020 - 01/2003
2	Estrogen ReceptorsIBA 02/2018 - 05/2013
2	Tamoxifen FDA LinkGeneric 02/2018 - 05/2013
2	dezocine FDA Link 01/2018 - 01/2017
2	Sirolimus (Rapamycin)FDA Link 06/2017 - 01/2008
2	IntegrinsIBA 01/2017 - 04/2015
2	Disulfiram (Antabuse)FDA Link 01/2017 - 11/2016
2	Peptides (Polypeptides)IBA 01/2017 - 04/2015

Therapy/Procedure

20	Therapeutics 01/2022 - 11/2006
18	Drug Therapy (Chemotherapy) 01/2022 - 10/2009
4	Radiotherapy 11/2020 - 01/2013
3	Precision Medicine 02/2019 - 04/2015
3	Aftercare (After-Treatment) 02/2018 - 08/2012
2	Immunotherapy 05/2021 - 04/2021
2	Anesthesia 01/2020 - 01/2017
2	Analgesia 01/2018 - 01/2017
2	Lasers (Laser) 01/2017 - 11/2016